LFWD stock forecast findings note revenue growth consistency over the last four quarters, a key element that maintains investor trust during volatile macro conditions. Investors in ReWalk Robotics Ltd. ( NASDAQ:LFWD ) had a good week, as its shares rose 6.3% to close at US$0.94 following the release of its yearly results. It was a moderately negative result overall - revenue fell 2.4% short of analyst estimates at US$14m, although at least statutory losses were marginally smaller than expected, at US$0.37 per share. The analyst typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimate to see what could be in store for next year. Lifeward finished the fourth quarter of 2024 with $7.5 million in revenue, up 10% from last year. Sales of ReWalk exoskeletons and related products dipped slightly due to training delays, but AlterG sales increased 17%, driven by strong international demand. Gross margin took a hit, dropping to 24.4% from 35.5%, mainly due to restructuring costs. The company ended the year with $6.7 million in cash and no debt. Looking ahead, Lifeward Ltd. (NASDAQ:LFWD) expects 2025 revenue to be between $28 million and $30 million, with improved gross margins of 47%-49% and a reduced operating loss of $7 million to $9 million. Market liquidity and recent insider purchase filings contribute positively to LFWD stock forecast, reinforcing confidence among retail investors and hedge funds aiming for early positioning.